Volume 5, Issue 1 supplement | EPMA Journal

Search all EPMA Journal articles

Volume 5, Issue 1 supplement

February 2014

Proceedings of the EPMA World Congress

Filter by

Volume:

Sort by

Date published:

New to old Old to new

165 articles in this issue

Horizon 2020: European perspectives in healthcare sciences and implementation
Irene Norstedt
Meeting abstract Open access 11 February 2014 Article: A1
Political regulations to advance health care system
Olga Golubnitschaja
Meeting abstract Open access 11 February 2014 Article: A2
Time for new guidelines in personalised healthcare: PPPM related legislation
Olga Golubnitschaja
Vincenzo Costigliola
Meeting abstract Open access 11 February 2014 Article: A3
Global strategies for non-communicable disease in terms of predictive, preventive and personalised medicine
Hiroyasu Iso
Yoshihiro Kokubo
Meeting abstract Open access 11 February 2014 Article: A4
EuroBioForum - the gateway to partnering in Europe
Wouter Spek
Meeting abstract Open access 11 February 2014 Article: A5
The FDA initiatives for personalized medicine
Olive Joy Wolfe
Meeting abstract Open access 11 February 2014 Article: A6
Corporate medicine is usurping the doctor-patient relationship in America
Russell J Andrews
Meeting abstract Open access 11 February 2014 Article: A7
Legislative initiatives can speed PPPM innovation in medicine
Trevor G Marshall
Meeting abstract Open access 11 February 2014 Article: A8
PPPM health care - United States style: political, profitable, and profligate medicine
Russell J Andrews
Meeting abstract Open access 11 February 2014 Article: A9
Work in progress, developing of guidelines - How could EPMA contribute to better health care in developing countries
Anna Benini
Meeting abstract Open access 11 February 2014 Article: A10
Boosting drug development through public-private partnerships – The IMI model
Hugh Laverty
Meeting abstract Open access 11 February 2014 Article: A11
Professional education in PPPM as the realistic platform for the medicine of the future: EPMA takes action
Olga Golubnitschaja
Meeting abstract Open access 11 February 2014 Article: A12
Healthcare overview: new perspectives
Vincenzo Costigliola
Meeting abstract Open access 11 February 2014 Article: A13
New strategies to advance pre/diabetes care: integrative approach by PPPM
Mahmood S Mozaffari
Meeting abstract Open access 11 February 2014 Article: A14
Drug delivery systems: advanced technologies potentially applicable in personalised treatment, educational measures
Jorge FJ Coelho
Meeting abstract Open access 11 February 2014 Article: A15
A new book “Rare Diseases: Integrative PPPM Approach as the Medicine of the Future”
Meral Özgüç
Meeting abstract Open access 11 February 2014 Article: A16
Individualized medicine – ethical, economical and historical perspectives
Tobias Fischer
Martin Langanke
Susanne Michl
Meeting abstract Open access 11 February 2014 Article: A17
Predictive, preventive, personalised and participatory periodontology: State of knowledge and future perspectives
Carlo Cafiero
Meeting abstract Open access 11 February 2014 Article: A18
Education in personalized medicine in Czech Republic
Marie Karlikova
Ondrej Topolcan
Radka Fuchsova
Meeting abstract Open access 11 February 2014 Article: A19
New international education project in predictive, preventive and personalized medicine
Olga Safonicheva
Meeting abstract Open access 11 February 2014 Article: A20
The activities of the young professionals EPMA in the Czech Republic
Jiri Polivka Jr
Pavla Sadilkova
Jiri Polivka
Meeting abstract Open access 11 February 2014 Article: A21
The Alexander von Humboldt-Foundation
Alexander von Humboldt-Stiftung
Meeting abstract Open access 11 February 2014 Article: A22
Personalised treatment for cancer: role of biomarkers
Michael J Duffy
Meeting abstract Open access 11 February 2014 Article: A23
A clinical pharmacogenetic characterization of DPD polymorphisms for pre-treatment screening of patients candidates to fluoropyrimidine therapy
Marzia Del Re
Fotios Loupakis
Romano Danesi
Meeting abstract Open access 11 February 2014 Article: A24
Multi-parameter systematic strategy opinion that predicts, prevents, and personalized treats a cancer
Xianquan Zhan
Rong Hu
Xiaowei Wang
Meeting abstract Open access 11 February 2014 Article: A25
Predictive markers in cancer patient diagnosis, classification and prediction of therapy outcome using leukaemia as a model
Godfrey Grech
Shawn Baldacchino
Anthony Fenech
Meeting abstract Open access 11 February 2014 Article: A26
Relevance of ERCC1, RRM1 and BRCA1 in surgically treated non-small cell lung cancer patients
Martin Pesta
Ondrej Topolcan
Milos Pesek
Meeting abstract Open access 11 February 2014 Article: A27
Genome-proteome system for prostate cancer
Maxim N Peshkov
Meeting abstract Open access 11 February 2014 Article: A28
Frequency of the DPYD * 2A allele in the Czech population
Monika Koudová
Martina Bittóová
Lucie Pavlíčková
Meeting abstract Open access 11 February 2014 Article: A29
Pitfalls and perspectives in cancer genomes NGS studies: implications for predictive, preventive and personalized medicine (PPPM)
Ugo Rovigatti
Meeting abstract Open access 11 February 2014 Article: A30
The application of personalized medicine in neurooncology
Jiri Polivka Jr
Jiri Polivka
Ondrej Topolcan
Meeting abstract Open access 11 February 2014 Article: A31
Comparing ion torrent with pyrosequencing and Sanger sequencing for the detection of TP53 mutations in colorectal cancer
Brendan Doyle
Clarence C Lee
Orla Sheils
Meeting abstract Open access 11 February 2014 Article: A32
Novel approaches such as pharmacogenetics and liquid biopsies in tumor treatment in the era of personalized therapy
Milena Kralickova
Vaclav Liska
Pavel Soucek
Meeting abstract Open access 11 February 2014 Article: A33
Possibilities for preventive and personalized therapy of cancer by drugs screening
Igor V Volchek
Tamara V Sologub
Andrei S Petrov
Meeting abstract Open access 11 February 2014 Article: A34
Preventive regimen of immunostimulants within personalised “3S” paradigm of anticancer drug testing
Ekaterina Moiseeva
Meeting abstract Open access 11 February 2014 Article: A35
Prognostic value of tumor markers in malignant melanoma
Inka Treskova
Jindra Vrzalova
Vladislav Treska
Meeting abstract Open access 11 February 2014 Article: A36
Serum levels of markers in early detection of prostate cancer (pilote study)
Radka Fuchsova
Ondrej Topolcan
Jiri Ferda
Meeting abstract Open access 11 February 2014 Article: A37
“Molecular signature” in blood of liver cancer diagnosed patients as a criterion for optimal therapy modalities
Olga Golubnitschaja
Melanie Cebioglu
Hans H Schild
Meeting abstract Open access 11 February 2014 Article: A38
Assessment of endometrial receptor systems for PPPM approach for endometrial hyperplasia in reproductive age women
Vadym M Goncharenko
Vasyl A Beniuk
Rostyslav V Bubnov
Meeting abstract Open access 11 February 2014 Article: A39
Personalized treatment strategy for atypical endometrial hyperplasia with regards to age, comorbidities and endometrial receptor status
Vadym M Goncharenko
Vasyl A Beniuk
Rostyslav V Bubnov
Meeting abstract Open access 11 February 2014 Article: A40
Challenges in breast cancer management and prevention
Manuel Debald
Walther Kuhn
Olga Golubnitschaja
Meeting abstract Open access 11 February 2014 Article: A41
Detection of KRAS mutant alleles in circulating cell-free tumor DNA in colorectal cancer patients resistant to cetuximab
Marzia Del Re
Paola Ulivi
Dino Amadori
Meeting abstract Open access 11 February 2014 Article: A42
Hepatic oncology diagnosis based on imaging fractal analysis: preliminary results
Rostyslav V Bubnov
Ivan M Melnyk
Meeting abstract Open access 11 February 2014 Article: A43
Personalized cancer care through biology informed treatment decisions
Peter Kuhn
Meeting abstract Open access 11 February 2014 Article: A44
CD133-regulated nucleophosmin expression in human colon cancer cells
Kun Kim
Kyung-Hee Kim
Ja-Lok Ku
Meeting abstract Open access 11 February 2014 Article: A45
Mechanism of anti-tumor and anti-invasive function of SOCS isoform in colon cancer models
Won Ki Kim
ji-Yoon Ryu
Choong-Eun Lee
Meeting abstract Open access 11 February 2014 Article: A46
HSP27 phosphorylation inhibitor regulates Her2 expression in human breast cancer cell line SK-BR-3 with induced Herceptin resistance
Min Kyung Kim
Seung Cheol Kim
Byong Chul Yoo
Meeting abstract Open access 11 February 2014 Article: A47
Concept of molecular prevention
Christoph A Karle
Giang Duong
Thomas M Helms
Meeting abstract Open access 11 February 2014 Article: A48
From integrative disease modeling to predictive, preventive, personalized and participatory (P4) medicine
Erfan Younesi
Martin Hofmann-Apitius
Meeting abstract Open access 11 February 2014 Article: A49
The role of informatics in the shift from reactive to proactive healthcare
Michael Legg
Meeting abstract Open access 11 February 2014 Article: A50

1
2
…
4
Next page